Friday 6 November 2026 Export ETON’s income statement to Excel — free account

Eton Pharmaceuticals, Inc.

ETON Healthcare Drug Manufacturers Specialty & Generic

Eton Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $80.0 million, up 104.9% from fiscal 2024.

Revenue: +157.9%
EPS: +1,857.1%
Free cash flow: +172.6%
Total debt: −24.0%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

54.21 7.06 +14.97%

Follow ETON

Alert me

Market cap: $1.4B
P/E: 26.8×
Fwd P/E: 48.0×
Dividend yield: —
F-score: 5/9
Altman Z: 3.55
Beneish M: −2.24
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 5 Nov
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	5	6	7
ROE Full definition →		(18.19%)	(5.36%)	35.97%	90.62%
ROA Full definition →		(5.47%)	(1.62%)	11.67%	38.10%
ROIC Full definition →		(1.71%)	3.06%	21.39%	46.77%
Return on Tangible Assets Full definition →		(20.52%)	(15.63%)	53.25%	115.90%
Average Days of Receivables Full definition →		53.67	56.29	86.02	68.38
Free Cash Flow per Share Full definition →		0.38	(0.28)	(0.30)	0.70
Free Cash Flow Full definition →		10.18	(7.70)	(8.39)	19.99
Capital Expenditures Full definition →		(0.34)	(23.54)	(23.52)	(18.36)
Other line items
Cash ROIC Full definition →		12.32%	(9.50%)	(8.28%)	12.07%
Accounts Receivable Turnover Full definition →		9.34	5.83	5.37	7.14
Accounts Payable Turnover Full definition →		4.91	4.28	3.35	2.83
Inventory Turnover Full definition →		2.43	2.80	2.62	3.12
Average Days of Payables Full definition →		107.67	125.18	118.17	138.40
Days of Inventory on Hand Full definition →		151.25	134.29	83.21	92.96
Tax Rate Full definition →		0.01	(0.01)	0.00	0.35
Research and Development Expense of Revenue Full definition →		9.71%	9.75%	5.45%	7.03%
Selling, General and Administrative Expense of Revenue Full definition →		44.80%	42.67%	36.97%	33.28%
Share Based Compensation of Revenue Full definition →		6.89%	6.71%	4.93%	5.26%
Interest Coverage Full definition →		—	0.58	4.59	12.86
Operating CF/Net income Full definition →		(2.29)	(10.74)	1.19	0.77
Depreciation/Fixed assets Full definition →		14.54	12.59	14.70	16.69
Capex/Depreciation Full definition →		(0.07)	(5.03)	(4.55)	(3.25)
Revenue per Share Full definition →		2.97	3.19	3.82	4.92
Operating CF per Share Full definition →		0.39	0.58	0.55	1.34
Capex per Share Full definition →		(0.01)	(0.86)	(0.85)	(0.64)
Capex to Sales Full definition →		0.00	0.27	0.22	0.13

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly